ASX Equity Snapshot

PTX Weekly Equity Report

Prescient Therapeutics Limited

Interactive chart JSON snapshot
Latest Close 0.07 AUD 12 Jun 2026
1W Return -6.8% latest completed week
4W Return 4.6% short-term follow-through
12W Return 21.4% quarterly tape
Trend Breadth 34.6% 18 of 52 weeks active
Volume Ratio 0.7x vs 13-week average
Company Brief

What the company does

Prescient Therapeutics Limited, a clinical stage oncology company, develops drugs for the treatment of haematological and solid cancers in Australia. Its lead drug candidate is PTX-100, a first in class targeted therapy which can disrupt the RAS family pathway by inhibiting the prenylation action of the enzyme GGT-1. The company was formerly known as Virax Holdings Limited and changed its name to Prescient Therapeutics Limited in December 2014. Prescient Therapeutics Limited was incorporated in 1986 and is based in Melbourne, Australia.

Snapshot

What the weekly tape is saying

PTX closed the latest completed week at 0.07 AUD. The 4-week return is 4.6% and the 12-week return is 21.4%. Trend Signal is inactive, Market Dynamics is 0.69. Setup signature: Deep recovery attempt with a 51/100 composite read.

Trend Signal Inactive
Market Dynamics No fresh buy
Price vs Trend -1.3%
Volume 0.7x
Setup Cockpit

A compressed read of the whole setup

The radar blends trend persistence, momentum, Market Dynamics, Relative Strength, volume confirmation, and risk control into one weekly cockpit.

Composite setup radar

Scoreboard

Trend 19 Persistence of active Trend Signal over the last year and current streak.
Momentum 80 Blend of 4-week and 12-week follow-through.
Dynamics 78 Latest Market Dynamics and whether pressure has improved over four weeks.
Relative Strength 97 Relative leadership and short-term RS change.
Volume 31 Participation compared with the 13-week volume baseline.
Risk Control 0 Drawdown and recent weekly volatility pressure.

16-week signal tape

27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun
Weekly return bar Trend Signal dot Positive Market Dynamics dot
Price Action

Price, Trend Line, and Fair Value

Weekly price context with the latest close, trend position, Fair Value gap, drawdown, and 52-week range location.

52-week price path

Price Trend Line Fair Value

Price map

Trend Line
0.07 AUD
Vs Trend Line
-1.3%
Fair Value
0.06 AUD
Vs Fair Value
23.6%
52W High
0.12 AUD
52W Low
0.04 AUD
Drawdown
-45.6%
Range Position
32.9%
Momentum

Returns and trend persistence

Return windows separate the latest week from short-term and medium-term follow-through.

Return windows

1W -6.8%
4W 4.6%
12W 21.4%
26W -23.6%
52W 30.8%

Trend read

Active Streak
0 weeks
52W Active Weeks
18
52W Active Breadth
34.6%
Sector Scope
AU Healthcare
Sector Rank
108 of 146
Sector Percentile
26.2%
Peer Context

Sector and industry pulse

Peer breadth helps separate a stock-specific move from a broader group rotation.

Market Dynamics

Pressure, Relative Strength, and expectation

Market Dynamics and Relative Strength show whether buying pressure and relative leadership are confirming the price move.

Dynamics path

Market Dynamics Relative Strength

Signal state

Market Dynamics
0.69
4W MD Change
195.9%
Relative Strength
15.74
4W RS Change
-5.9%
Expectation
Negative
Probability
38.35%
Volume

Participation and confirmation

Volume tells us whether the latest weekly move is being confirmed by unusual participation.

52-week volume profile

Volume map

Latest Volume
3.0M
13W Average
4.2M
52W Average
6.6M
Vs 13W
0.7x
Vs 52W
0.5x
Risk Anatomy

Volatility, downside weeks, and return shape

A compact risk profile shows whether the move is steady, volatile, or being driven by sharp one-week jumps.

26-week return distribution

Risk map

13W Volatility
10.3%
52W Volatility
9.8%
Upside Weeks
23
Downside Weeks
26
Downside Breadth
50.0%
Avg Gain / Loss
9.1% / -6.1%
Context

Classification, opportunities, risks, and watch points

Top-level read across company classification, constructive evidence, caution points, and the next things that matter.

Classification

Exchange
ASX
Country
AU
Sector
Healthcare
Industry
Biotechnology
Currency
AUD
Market Cap
82.0M

Opportunity signals

  • Price is above Fair Value, showing premium demand versus the model.
  • Market Dynamics is positive on the latest completed week.

Risk signals

  • Trend Signal is inactive, so price action has not confirmed a constructive regime.
  • Price is below the Trend Line, which keeps downside pressure in focus.
  • The share remains more than 20% below its 52-week high.
  • The latest week was a sharp negative move.

Watch next

  • Trend Line remains the key weekly regime level.
  • Market Dynamics is the pressure gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Weekly Tape

Recent completed weeks

The latest weekly rows behind the report snapshot.

Week Close Return Trend Fair Value MD RS Volume Signal
12 Jun 2026 0.07 AUD -6.8% 0.07 AUD 0.06 AUD 0.69 15.74 3.0M Off
5 Jun 2026 0.07 AUD -6.4% 0.07 AUD 0.06 AUD 0.67 27.42 4.4M Off
29 May 2026 0.08 AUD -4.9% 0.07 AUD 0.06 AUD 0.26 35.51 6.4M Off
22 May 2026 0.08 AUD 26.2% 0.07 AUD 0.06 AUD -0.19 45.16 6.0M Off
15 May 2026 0.07 AUD 20.4% 0.07 AUD 0.06 AUD -0.72 16.72 5.7M Off
8 May 2026 0.05 AUD 0.0% 0.06 AUD 0.06 AUD -1.08 -3.85 3.0M Off
1 May 2026 0.05 AUD 0.0% 0.06 AUD 0.06 AUD -1.12 -3.70 6.7M Off
24 Apr 2026 0.05 AUD 5.9% 0.06 AUD 0.06 AUD -1.21 -4.18 3.8M Off
17 Apr 2026 0.05 AUD -8.9% 0.06 AUD 0.06 AUD -1.22 -11.13 4.2M Off
10 Apr 2026 0.06 AUD 7.7% 0.06 AUD 0.06 AUD -1.19 -2.58 1.7M Off
3 Apr 2026 0.05 AUD -1.9% 0.06 AUD 0.06 AUD -1.15 -5.31 3.6M Off
27 Mar 2026 0.05 AUD -5.4% 0.06 AUD 0.06 AUD -1.09 -2.64 2.2M Off
20 Mar 2026 0.06 AUD -3.4% 0.06 AUD 0.06 AUD -0.94 4.01 3.4M Off
13 Mar 2026 0.06 AUD -3.3% 0.06 AUD 0.06 AUD -0.82 5.60 6.0M On